WaveMan · Form 4
Curley Joanne insider trades
> Search tickers & screens ⌘K
LIVE

Curley Joanne insider trades

Curley Joanne has filed 24 Form 4s with the SEC that we hold, for Vera Therapeutics, Inc. (VERA) (Chief Development Officer) and Vistagen Therapeutics, Inc. (VTGN) (Director). Across all of them we count 0 purchases worth $0 and 48 sales worth $1.8M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 11,733 shares of Vera Therapeutics, Inc. worth $214.5K, dated 2022-12-13. The first filing on our record is dated 2022-02-18 and the latest 2025-09-11.

Vera Therapeutics, Inc. (VERA)

Chief Development Officer · 20 filings · 48 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-31S, sale reported on Form 4400$6.1K2022-06-02
2022-06-17S, sale reported on Form 41,346$20.3K2022-06-21
2022-06-17S, sale reported on Form 43,341$50.2K2022-06-21
2022-06-17S, sale reported on Form 41,200$18.1K2022-06-21
2022-06-22S, sale reported on Form 4306$4.6K2022-06-23
2022-06-22S, sale reported on Form 41,239$18.6K2022-06-23
2022-07-07S, sale reported on Form 43,514$53.0K2022-07-11
2022-07-07S, sale reported on Form 42,665$40.1K2022-07-11
2022-07-07S, sale reported on Form 43,487$52.4K2022-07-11
2022-07-14S, sale reported on Form 42,750$41.7K2022-07-15
2022-07-14S, sale reported on Form 46,354$96.1K2022-07-15
2022-07-19S, sale reported on Form 45,384$86.3K2022-07-20
2022-07-19S, sale reported on Form 46$992022-07-20
2022-07-19S, sale reported on Form 48$1322022-07-20
2022-07-19S, sale reported on Form 46,046$96.8K2022-07-20
2022-08-03S, sale reported on Form 4988$16.6K2022-08-04
2022-08-19S, sale reported on Form 4378$7.1K2022-08-23
2022-08-19S, sale reported on Form 4700$13.8K2022-08-23
2022-08-19S, sale reported on Form 4710$13.4K2022-08-23
2022-08-19S, sale reported on Form 41,451$28.8K2022-08-23
2022-08-19S, sale reported on Form 42,766$51.5K2022-08-23
2022-08-19S, sale reported on Form 4904$17.9K2022-08-23
2022-08-22S, sale reported on Form 41,030$19.0K2022-08-23
2022-08-22S, sale reported on Form 4600$11.8K2022-08-23
2022-09-07S, sale reported on Form 4988$18.4K2022-09-08
2022-09-20S, sale reported on Form 41,828$37.4K2022-09-22
2022-09-20S, sale reported on Form 410,112$210.3K2022-09-22
2022-09-20S, sale reported on Form 4978$20.1K2022-09-22
2022-09-20S, sale reported on Form 4100$2.1K2022-09-22
2022-09-20S, sale reported on Form 4334$7.0K2022-09-22
2022-09-20S, sale reported on Form 42,314$46.8K2022-09-22
2022-09-21S, sale reported on Form 4910$19.2K2022-09-22
2022-09-21S, sale reported on Form 4264$5.9K2022-09-22
2022-10-05S, sale reported on Form 4988$21.4K2022-10-06
2022-10-18S, sale reported on Form 42,212$42.9K2022-10-20
2022-10-18S, sale reported on Form 41,078$20.9K2022-10-20
2022-10-18S, sale reported on Form 45,298$102.9K2022-10-20
2022-10-18S, sale reported on Form 42$412022-10-20
2022-11-09S, sale reported on Form 4494$8.2K2022-11-10
2022-11-17S, sale reported on Form 41,078$17.1K2022-11-21
2022-11-17S, sale reported on Form 42,211$35.0K2022-11-21
2022-12-07S, sale reported on Form 4494$8.1K2022-12-08
2022-12-12S, sale reported on Form 46,900$125.9K2022-12-14
2022-12-13S, sale reported on Form 411,733$214.5K2022-12-14
2022-12-13S, sale reported on Form 41,078$19.6K2022-12-14
2022-12-16S, sale reported on Form 4783$15.8K2022-12-19
2022-12-16S, sale reported on Form 41,429$27.3K2022-12-19
2023-08-21S, sale reported on Form 41,490$24.8K2023-08-23

Vistagen Therapeutics, Inc. (VTGN)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1857670) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms